https://cancerexplained.org/news/sonrotoclax-mantle-cell-lymphoma-accelerated-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Grants Accelerated Approval to Sonrotoclax for Relapsed Mantle Cell Lymphoma https://cancerexplained.org/news/pembrolizumab-enfortumab-muscle-invasive-bladder-cancer-fda-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Expands Pembrolizumab and Enfortumab Vedotin Around Bladder Surgery https://cancerexplained.org/news/isatuximab-subcutaneous-multiple-myeloma-fda-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Approves Subcutaneous Isatuximab for Multiple Myeloma Indications https://cancerexplained.org/news/gedatolisib-fulvestrant-breast-cancer-fda-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Approves Gedatolisib for Some HR-Positive, HER2-Negative Breast Cancers https://cancerexplained.org/news/capivasertib-pten-prostate-cancer-fda-approval Cancer Explained en 2026-07-20T12:00:00.000Z FDA Approves Capivasertib for PTEN-Deficient Metastatic Prostate Cancer